1.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 75 Sponsor: Pharmaceutical / Industry Protocol IDs: P04602, NCT00424554
|
|
2.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: Over 18 Sponsor: Other Protocol IDs: EPI-GLIO-LEV, NCT00454935
|
|
3.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: HELLO-Study 2007, EudraCT Number: 2007-005063-96, NCT00571155
|
|
4.
|
Phase: Phase IV Type: Diagnostic Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 91780, EudraCT 2007-005693-31, 312021, NCT00764387
|
|
5.
|
Phase: Phase III, Phase II Type: Diagnostic Status: Active Age: 15 and over Sponsor: Other Protocol IDs: SP-11-0035, NCT00123760
|
|
6.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MRC-BR12, EU-20114, ISRCTN83176944, NCT00052455
|
|
7.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: NTI-0303, BCM-H-14962, NCT00088166
|
|
8.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0320, NCT00096265
|
|
9.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 021108, NCT00124761
|
|
10.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EORTC-22033, EORTC-26033, EudraCT-2004-002714-11, CAN-NCIC-CE5, NCT00182819, TROG 06.01, CE5
|
|
11.
|
Phase: Phase III Type: Diagnostic Status: Active Age: 19 to 90 Sponsor: Other Protocol IDs: R05-0076, NCT00207298
|
|
12.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: TASMC-05-FB-05235-CTIL, NCT00268684
|
|
13.
|
Phase: Phase III Type: Educational/Counseling/Training Status: Active Age: 11 to 24 Sponsor: NCI, NINR Protocol IDs: COG-ANUR0631, NCT00305851
|
|
14.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0525, EORTC-26052, EORTC-22053, NCT00304031
|
|
15.
|
Phase: Phase III Type: Treatment Status: Active Age: 20 to 79 Sponsor: Other Protocol IDs: JCOG0504, C000000307, NCT00280475
|
|
16.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CCCWFU-91105, WFU 91105, NCT00369785
|
|
17.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 04U.534, NCT00328510
|
|
18.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N0574, N0574, ACOSOG-N0574, NCT00377156
|
|
19.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: MRC-LU24-QUARTZ, EU-20653, ISRCTN3826061, NCT00403065, TROG 07.02
|
|
20.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: P050320, NCT00389883
|
|
21.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: HYT105962, NCT00390806
|
|
22.
|
Phase: Phase III Type: Health services research Status: Active Age: 18 and over Sponsor: Other Protocol IDs: SWS-SAKK-95/06, SAKK-95/06, EU-20711, SWS-SAKK-E-MOSAIC, NCT00477919
|
|
23.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 65 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: CAN-NCIC-CE6, EORTC-26062, EORTC-22061, CE6, SPRI-CAN-NCIC-CE.6, NCT00482677
|
|
24.
|
Phase: Phase III Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2005-0398, NCT00500890
|
|
25.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0614, RTOG 0614, NCT00566852
|